Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis

Oncology Letters

Volumn 7, Issue 5, 2014, Pages 1549-1555

  Zhou, Xiaoqing ^a   Huang, Shengyun ^b   Jiang, Licheng ^c   Zhang, Shizhou ^b   Li, Wengang ^b   Chen, Zhanwei ^b   Zhang, Dongsheng ^b  

^a Jining First People's Hospital   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c Liaocheng Hospital   (China)

Author keywords

Adenoid cystic carcinoma; MMP 2; Prognosis; RECK

Indexed keywords

GELATINASE A;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; CYSTINE KNOT MOTIF; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING;

EID: 84896312170     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1906     Document Type: Article

References (29)

1. van der Wal JE, Becking AG, Snow GB and van der Waal I: Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck 24: 779-783, 2002.
2. Terhaard CH, Lubsen H, Van der Tweel I, et al: Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 26: 681-693, 2004.
3. Honma K, Miyata T and Ochiya T: Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells. Cancer Cell Int 7: 12, 2007.
4. López-Otín C and Matrisian LM: Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7: 800-808, 2007.
5. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003.
6. Takahashi C, Sheng Z, Horan TP, et al: Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95: 13221-13226, 1998.
7. Hsu MC, Chang HC and Hung WC: HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J Biol Chem 281: 4718-4725, 2006.
8. Welm B, Mott J and Werb Z: Developmental biology: vasculogenesis is a wreck without RECK. Curr Biol 12: R209-R211, 2002.
9. Sasahara RM, Brochado SM, Takahashi C, et al: Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detect Prev 26: 435-443, 2002.
10. Takagi S, Simizu S and Osada H: RECK negatively regulates matrix metalloproteinase-9 transcription. Cancer Res 69: 1502-1508, 2009.
11. Takenaka K, Ishikawa S, Yanagihara K, et al: Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer. Ann Surg Oncol 12: 817-824, 2005.
12. Span PN, Sweep CG, Manders P, Beex LV, Leppert D and Lindberg RL: Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer 97: 2710-2715, 2003.
13. Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM and Han I: RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. J Orthop Res 25: 696-702, 2007.
14. Ko YH, Roh SY, Won HS, et al: Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck. Head Neck Oncol 2: 30, 2010.
15. Seifert G and Sobin LH: The World Health Organization's Histological Classification of Salivary Gland Tumors. A commentary on the second edition. Cancer 70: 379-385, 1992.
16. Lee JH and Welch DR: Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57: 2384-2387, 1997.
17. Welch DR, Steeg PS and Rinker-Schaeffer CW: Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res 2: 408-416, 2000.
18. Yang J, Mani SA, Donaher JL, et al: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939, 2004.
19. Shirasuna K, Saka M, Hayashido Y, Yoshioka H, Sugiura T and Matsuya T: Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation. Cancer Res 53: 147-152, 1993.
20. Vihinen P and Kähäri VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99: 157-166, 2002.
21. Freitas VM, Vilas-Boas VF, Pimenta DC, et al: SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway. Am J Pathol 171: 124-138, 2007.
22. Takeuchi T, Hisanaga M, Nagao M, et al: The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin Cancer Res 10: 5572-5579, 2004.
23. Oh J, Takahashi R, Kondo S, et al: The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107: 789-800, 2001.
24. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
25. Sasahara RM, Takahashi C and Noda M: Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun. 264: 668-675, 1999.
26. Masui T, Doi R, Koshiba T, et al: RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res 9: 1779-1784, 2003.
27. Furumoto K, Arii S, Mori A, et al: RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing-cysteine-rich protein with Kazal motifs. Hepatology 33: 189-195, 2001.
28. Yang X, Dai J, Li T, et al: Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis. Oral Oncol 46: 755-760, 2010.
29. Yan KH, Lee LM, Yan SH, Huang HC, Li CC, Lin HT and Chen PS: Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression. Chem Biol Interact 203: 580-587, 2013.